Natural history of t(11;14) multiple myeloma (MM).

被引：2
|
作者：
Lakshman, Arjun
Moustafa, Muhamad Alhaj
Rajkumar, S. Vincent
Dispenzieri, Angela
Gertz, Morie A.
Buadi, Francis
Lacy, Martha
Dingli, David
Hayman, Suzanne R.
Gonsalves, Wilson I.
Kapoor, Prashant
Leung, Nelson
Lin, Yi
Go, Ronald S.
Kourelis, Taxiarchis
Lust, John Anthony
Russell, Stephen
Zeldenrust, Steven R.
Kyle, Robert A.
Kumar, Shaji
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.8014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8014
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Impact of Novel Agents on Young Patients with t(11;14) Multiple Myeloma
    Paludo, Jonas
    Vallumsetla, Nishanth
    Kumar, Shaji
    Ketterling, Rhett
    Gertz, Morie A.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Buadi, Francis K.
    Dingli, David
    Painuly, Utkarsh
    Leung, Nelson
    Kyle, Robert
    Rajkumar, S. Vincent
    Kapoor, Prashant
    BLOOD, 2014, 124 (21)
  • [22] Prognostic Impact of t(11;14) in Newly Diagnosed Patients With Multiple Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Terpos, Evangelos
    Briasoulis, Alexandros
    Malandrakis, Panagiotis
    Fotiou, Despina
    Migkou, Magdalini
    Spiliopoulou, Vasiliki
    Theodorakakou, Foteini
    Filippatos, Charalampos
    Roussou, Maria
    Kanellias, Nikolaos
    Eleftherakis-Papaiakovou, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios
    Gavriatopoulou, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S238 - S239
  • [23] Activity and Safety of Venetoclax (VEN)-Based Treatment in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (R/R MM)
    Ionescu, Filip
    Thapa, Shrinjaya B.
    Patel, Parth C.
    Drekolias, Dimitrios
    Silva, Ariosto Siqueira
    Sudalagunta, Praneeth R.
    Agius, Phaedra
    Blue, Brandon
    Hansen, Doris K.
    Castaneda, Omar
    Liu, Hien
    Ochoa-Bayona, Jose L.
    Freeman, Ciara Louise
    Locke, Frederick
    Nishihori, Taiga
    Alsina, Melissa
    Shain, Kenneth H.
    Baz, Rachid
    Grajales-Cruz, Ariel
    BLOOD, 2024, 144 : 4740 - 4741
  • [24] Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study
    Kumar, Shaji K.
    Lu, Jin
    Liu, Yang Terry
    Bittrich, Max
    Du, Juan
    Goldschmidt, Hartmut
    Kyriakou, Charalampia
    Reece, Donna E.
    Kim, Kihyun
    Mateos, Maria-Victoria
    De La Calle, Veronica Gonzalez
    Chen, Wenming
    Ludwig, Heinz
    Merlini, Giampaolo
    Mangiacavalli, Silvia
    Dimopoulos, Meletios A.
    Kastritis, Eftathios
    Min, Chang-Ki
    Esteves, Graca
    Yee, Andrew J.
    Raje, Noopur S.
    Rosta, Emily
    Haltner, Anja
    Cameron, Chris
    Durie, Brian G. M.
    BLOOD, 2019, 134
  • [25] TRANSLOCATION 11,14 AND BCL-1 GENE ABNORMALITIES IN MULTIPLE-MYELOMA (MM)
    TRAVIS, P
    SAWYER, J
    LARY, C
    HOOVER, R
    BARLOGIE, B
    BLOOD, 1993, 82 (10) : A261 - A261
  • [26] Longitudinal Analysis of t(11;14) and t(4;14) Genomes Reveals Distinct Evolutionary Trajectories in Multiple Myeloma
    Hudson-Lund, Bethan
    Hughes, Daniel
    Sodi, Isabella
    Foster, Kane
    Lyon, Emma
    Laidler, Annabel
    Rees, Elise
    Galas-Filipowicz, Daria
    Fitzsimons, Evie
    Chavda, Selina
    Rashid, Ambreen
    Lecat, Catherine
    Mehta, Dipal
    Rahman, Jasmin
    Yoon, Jong Won
    Lee, Lydia
    Quezada, Sergio
    Srinivasan, Anandagopal
    Kazeroun, Mohammad
    Ansari-Pour, Naser
    Thakurta, Anjan
    Yong, Kwee
    Cribbs, Adam
    Gooding, Sarah
    Boyle, Eileen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S163 - S164
  • [27] T(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma
    Garand, R
    Avet-Loiseau, H
    Accard, F
    Moreau, P
    Harousseau, JL
    Bataille, R
    LEUKEMIA, 2003, 17 (10) : 2032 - 2035
  • [28] t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma
    R Garand
    H Avet-Loiseau
    F Accard
    P Moreau
    J L Harousseau
    R Bataille
    Leukemia, 2003, 17 : 2032 - 2035
  • [29] Natural history of multiple myeloma (MM) relapsing after autologous stem cell transplantation (ASCT)
    Madan, S.
    Kumar, S.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Buadi, F. K.
    Dingli, D.
    Rajkumar, S. V.
    Gertz, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma
    Paner, Agne
    Patel, Pritesh
    Dhakal, Binod
    BLOOD REVIEWS, 2020, 41
12345